Clinical trial testing fecal microbiota transplant for recurrent diarrheal disease begins

(NIH/National Institute of Allergy and Infectious Diseases) A research consortium recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema--putting stool from a healthy donor in the colon of a recipient--is safe and can prevent recurrent Clostridium difficile-associated disease (CDAD), a potentially life-threatening diarrheal illness. Investigators aim to enroll 162 volunteer participants 18 years or older who have had two or more episodes of CDAD within the previous six months. (Source: EurekAlert! - Infectious and Emerging Diseases)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2sqXaIU